ES440030A1 - Un procedimiento para preparar nuevos derivados de 2-ami- noindano. - Google Patents

Un procedimiento para preparar nuevos derivados de 2-ami- noindano.

Info

Publication number
ES440030A1
ES440030A1 ES440030A ES440030A ES440030A1 ES 440030 A1 ES440030 A1 ES 440030A1 ES 440030 A ES440030 A ES 440030A ES 440030 A ES440030 A ES 440030A ES 440030 A1 ES440030 A1 ES 440030A1
Authority
ES
Spain
Prior art keywords
formula
radical
see formula
see
aminoindane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES440030A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Christiaens SA
Original Assignee
A Christiaens SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Christiaens SA filed Critical A Christiaens SA
Publication of ES440030A1 publication Critical patent/ES440030A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
ES440030A 1972-09-18 1975-08-05 Un procedimiento para preparar nuevos derivados de 2-ami- noindano. Expired ES440030A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB4315072 1972-09-18
GB998773*[A GB1405444A (en) 1972-09-18 1973-03-01 2-aminoindane derivatives
GB998873 1973-03-01
GB1030373 1973-03-02

Publications (1)

Publication Number Publication Date
ES440030A1 true ES440030A1 (es) 1977-02-16

Family

ID=27447738

Family Applications (3)

Application Number Title Priority Date Filing Date
ES418827A Expired ES418827A1 (es) 1972-09-18 1973-09-17 Un procedimiento para preparar nuevos derivados 2-aminoinda-no.
ES440029A Expired ES440029A1 (es) 1972-09-18 1975-08-05 Un procedimiento para preparar nuevos derivados de 2-ami- noindano.
ES440030A Expired ES440030A1 (es) 1972-09-18 1975-08-05 Un procedimiento para preparar nuevos derivados de 2-ami- noindano.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES418827A Expired ES418827A1 (es) 1972-09-18 1973-09-17 Un procedimiento para preparar nuevos derivados 2-aminoinda-no.
ES440029A Expired ES440029A1 (es) 1972-09-18 1975-08-05 Un procedimiento para preparar nuevos derivados de 2-ami- noindano.

Country Status (13)

Country Link
JP (1) JPS5327263B2 (es)
AR (4) AR206505A1 (es)
CA (1) CA992547A (es)
CH (1) CH585690A5 (es)
DD (2) DD109802A5 (es)
ES (3) ES418827A1 (es)
FR (1) FR2199988B1 (es)
GB (1) GB1405444A (es)
HU (1) HU168018B (es)
IL (1) IL43218A (es)
LU (1) LU68426A1 (es)
MX (1) MX3233E (es)
NL (1) NL152246B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975461A (en) * 1986-06-19 1990-12-04 E. R. Squibb & Sons, Inc. P-aminophenols, derivatives thereof and method of use
JPH0293610U (es) * 1989-01-09 1990-07-25
EP1658847A3 (en) * 1999-06-10 2006-07-26 Bridge Pharma, Inc. Indane derivatives as dermal anesthetic agents
NZ515143A (en) * 1999-06-10 2004-05-28 Bridge Pharma Inc Aminoindane piperidine compounds as dermal anesthetic agents
WO2001021206A1 (en) 1999-09-17 2001-03-29 Suntory Limited PREVENTIVES OR REMEDIES FOR MYOCARDITIS, DILATED CARDIOMYOPATHY AND CARDIAC INSUFFICIENCY CONTAINING NF-λB INHIBITORS AS THE ACTIVE INGREDIENT
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
US7592458B2 (en) 2006-07-21 2009-09-22 Wright George E Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain

Also Published As

Publication number Publication date
ES418827A1 (es) 1977-02-01
AU6028373A (en) 1975-03-13
AR206505A1 (es) 1976-07-30
LU68426A1 (es) 1973-11-26
AR203500A1 (es) 1975-09-15
MX3233E (es) 1980-08-05
NL7312776A (es) 1974-03-20
CH585690A5 (es) 1977-03-15
JPS5327263B2 (es) 1978-08-07
GB1405444A (en) 1975-09-10
DD108277A5 (es) 1974-09-12
FR2199988B1 (es) 1977-11-25
IL43218A (en) 1977-05-31
HU168018B (es) 1976-02-28
DD109802A5 (es) 1974-11-20
CA992547A (en) 1976-07-06
FR2199988A1 (es) 1974-04-19
AR205891A1 (es) 1976-06-15
AR204247A1 (es) 1975-12-10
IL43218A0 (en) 1973-11-28
JPS4969648A (es) 1974-07-05
ES440029A1 (es) 1977-02-16
DE2346337B2 (de) 1976-08-26
NL152246B (nl) 1977-02-15
DE2346337A1 (de) 1974-04-04

Similar Documents

Publication Publication Date Title
ES307300A1 (es) Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos.
ES462422A1 (es) Procedimiento para la preparacion de compuestos derivados den-alquil-sulfo-noxi-acetil-anilinas.
ES457993A1 (es) Un procedimiento para la preparacion de una isotiazolopiri- dina.
ES440029A1 (es) Un procedimiento para preparar nuevos derivados de 2-ami- noindano.
ES397370A1 (es) Procedimiento para la preparacion de un compuesto tranqui- lizante.
ES421067A1 (es) Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas sustituidas.
ES423233A1 (es) Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas-(2) sustituidas.
ES389360A1 (es) Procedimiento para la preparacion de acidos ariloxi- o bienariltioalcanicos.
ES463784A1 (es) Un procedimiento para la preparacion de un compuesto cis.
ES406098A1 (es) Procedimiento para la obtencion de derivados de 2,6-dini- tro-3,4-xilidena.
ES410855A1 (es) Procedimiento para la obtencion de derivados de benzociclo-heptatiofeno.
ES399003A1 (es) Procedimiento para la preparacion de 2-arilamino-imidazoli-nas-(2) sustituidas.
ES401342A1 (es) Procedimiento para la preparacion de nuevos derivados de lapiridina y de sus sales.
ES423745A1 (es) Procedimiento para preparar derivados de 2-aminoindano.
ES402551A1 (es) Un procedimiento para la preparacion de derivados de pipe- razina.
ES417269A1 (es) Procedimiento para preparar derivados de imidazolidinona.
ES451741A2 (es) Procedimiento para preparar derivados de naftiridina.
ES413742A1 (es) Un procedimiento para la preparacion de compuestos de acidol-alfa-hidrazino-betaf-fenilpropionico.
ES445922A1 (es) Procedimiento para preparar derivados de benzofuranona.
ES402749A1 (es) Un procedimiento para la preparacion de derivados de tieno-diacepina.
ES393339A1 (es) Un procedimiento para la preparacion de derivados de nafto-quinona.
ES454421A1 (es) Procedimiento para preparar derivados de acetamidoxina.
ES451291A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina.
ES398368A1 (es) Un procedimiento para la preparacion de nuevos derivados de1,2,3,4 - tetrahidroisoquinoleina.
ES391118A1 (es) Un procedimiento para la preparacion de un nuevo derivado de acido fluoronico.